• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与餐后胰多肽分泌受损有关。

Obesity is associated with impaired postprandial pancreatic polypeptide secretion.

机构信息

Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao, China.

Medical Research Center, Qingdao Key Laboratory of Thyroid Diseases, Qingdao, China.

出版信息

Front Endocrinol (Lausanne). 2023 Jun 2;14:1192311. doi: 10.3389/fendo.2023.1192311. eCollection 2023.

DOI:10.3389/fendo.2023.1192311
PMID:37334299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10273268/
Abstract

OBJECTIVE

This study aims to compare the levels of serum pancreatic polypeptide (PP), insulin (INS), C-peptide (C-P), and glucagon (GCG) before and after glucose stimulation in type 2 diabetes mellitus (T2DM) patients with different body mass indexes (BMI), analyze the relevant factors associated with PP secretion, and further investigate the role of PP in the development of obesity and diabetes.

METHODS

Data were collected from 83 patients from the hospital. The subjects were divided into normal-weight group, overweight group, and obese group according to their BMI. All subjects were tested with the standard bread meal test (SBMT). PP and relevant parameters were measured, and the area under the curve (AUC) was calculated after 120 min of SBMT. AUC (AUC of PP) was used as the dependent variable, and the potential influencing factors were used as independent variables for multiple linear regression analysis.

RESULTS

The obese and overweight groups had significantly lower PP secretion than the normal-weight group (485.95 pg·h/ml, 95% CI 76.16-895.74, = 0.021; 664.61 pg·h/ml, 95% CI 285.46-1043.77, = 0.001) at 60 min postprandial. PP secretion in the obese and overweight groups was also significantly lower than that in the normal-weight group (520.07 pg·h/ml, 95% CI 186.58-853.56, = 0.003; 467.62 pg·h/ml, 95% CI 159.06-776.18, = 0.003) at 120 min postprandial. AUC was negatively associated with BMI (r = -0.260, = 0.017) and positively associated with AUC (r = 0.501, 0.001). Multiple linear regression analysis showed that there was a linear correlation between AUC, BMI, and AUC ( 0.001, = 0.008). The regression equation was calculated as follows: AUC = 1772.255-39.65 × BMI + 0.957 × AUC (R54.1%, 0.001).

CONCLUSION

Compared with normal-weight subjects, overweight and obese subjects had impaired PP secretion after glucose stimulation. In T2DM patients, PP secretion was mainly affected by BMI and GCG.

CLINICAL TRIAL REGISTRY

The Ethics Committee of the Affiliated Hospital of Qingdao University.

CLINICAL TRIAL REGISTRATION

http://www.chictr.org.cn, identifier ChiCTR2100047486.

摘要

目的

本研究旨在比较不同体重指数(BMI)的 2 型糖尿病(T2DM)患者在葡萄糖刺激前后血清胰多肽(PP)、胰岛素(INS)、C 肽(C-P)和胰高血糖素(GCG)水平,分析与 PP 分泌相关的因素,并进一步探讨 PP 在肥胖和糖尿病发展中的作用。

方法

从医院收集了 83 名患者的数据。根据 BMI 将受试者分为正常体重组、超重组和肥胖组。所有受试者均接受标准面包餐试验(SBMT)检测。测量 PP 及相关参数,并计算 SBMT 后 120 min 的曲线下面积(AUC)。以 AUC(PP 的 AUC)为因变量,以潜在影响因素为自变量进行多元线性回归分析。

结果

餐后 60 min,肥胖组和超重组的 PP 分泌明显低于正常体重组(485.95 pg·h/ml,95%CI 76.16-895.74, = 0.021;664.61 pg·h/ml,95%CI 285.46-1043.77, = 0.001)。餐后 120 min,肥胖组和超重组的 PP 分泌也明显低于正常体重组(520.07 pg·h/ml,95%CI 186.58-853.56, = 0.003;467.62 pg·h/ml,95%CI 159.06-776.18, = 0.003)。AUC 与 BMI 呈负相关(r = -0.260, = 0.017),与 AUC 呈正相关(r = 0.501, 0.001)。多元线性回归分析显示,AUC、BMI 和 AUC 之间存在线性关系( 0.001, = 0.008)。计算回归方程如下:AUC = 1772.255-39.65 × BMI + 0.957 × AUC(R54.1%, 0.001)。

结论

与正常体重受试者相比,超重和肥胖的葡萄糖刺激后 PP 分泌受损。在 T2DM 患者中,PP 分泌主要受 BMI 和 GCG 影响。

临床试验注册

青岛大学附属医院伦理委员会。

临床试验注册

http://www.chictr.org.cn,标识符 ChiCTR2100047486。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/d98b695073cb/fendo-14-1192311-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/74639d97ea21/fendo-14-1192311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/cbd4a4cfe213/fendo-14-1192311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/3c86ffedc29c/fendo-14-1192311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/d98b695073cb/fendo-14-1192311-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/74639d97ea21/fendo-14-1192311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/cbd4a4cfe213/fendo-14-1192311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/3c86ffedc29c/fendo-14-1192311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e240/10273268/d98b695073cb/fendo-14-1192311-g004.jpg

相似文献

1
Obesity is associated with impaired postprandial pancreatic polypeptide secretion.肥胖与餐后胰多肽分泌受损有关。
Front Endocrinol (Lausanne). 2023 Jun 2;14:1192311. doi: 10.3389/fendo.2023.1192311. eCollection 2023.
2
Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion.糖耐量受损与餐后胰多肽分泌增强有关。
J Diabetes. 2022 May;14(5):334-344. doi: 10.1111/1753-0407.13268. Epub 2022 Apr 19.
3
Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes.内脏脂肪与胰岛素分泌和敏感性相关,与 BMI 和 2 型糖尿病中国患者的皮下脂肪无关。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1144834. doi: 10.3389/fendo.2023.1144834. eCollection 2023.
4
Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.胰高血糖素反应对糖耐量受损男性和2型糖尿病患者餐后高血糖的影响。
Metabolism. 2005 Sep;54(9):1168-73. doi: 10.1016/j.metabol.2005.03.024.
5
Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus.GLP-1 受体激动剂对 2 型糖尿病正常体重或超重/肥胖患者 asparagin 水平的影响。
Medicine (Baltimore). 2022 Oct 28;101(43):e31334. doi: 10.1097/MD.0000000000031334.
6
Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.在2型糖尿病患者与非2型糖尿病患者中,对胆碱能输入的激素反应有所不同。
PLoS One. 2016 Jun 15;11(6):e0156852. doi: 10.1371/journal.pone.0156852. eCollection 2016.
7
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.餐后胰岛素和肠促胰岛素激素释放对进餐诱导饱腹感的作用——肥胖与体重减轻的影响
Int J Obes Relat Metab Disord. 2001 Aug;25(8):1206-14. doi: 10.1038/sj.ijo.0801655.
8
Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance.胰腺癌相关糖尿病的特点是β细胞分泌能力下降,而不是胰岛素抵抗。
Diabetes Res Clin Pract. 2022 Mar;185:109223. doi: 10.1016/j.diabres.2022.109223. Epub 2022 Feb 8.
9
Impaired pancreatic polypeptide response to insulin hypoglycemia in obese subjects.
Horm Metab Res. 1985 Dec;17(12):663-6. doi: 10.1055/s-2007-1013638.
10
Association between osteocalcin, a pivotal marker of bone metabolism, and secretory function of islet beta cells and alpha cells in Chinese patients with type 2 diabetes mellitus: an observational study.骨代谢关键标志物骨钙素与中国2型糖尿病患者胰岛β细胞和α细胞分泌功能之间的关联:一项观察性研究。
Diabetol Metab Syndr. 2022 Oct 28;14(1):160. doi: 10.1186/s13098-022-00932-8.

引用本文的文献

1
Novel enzyme-resistant pancreatic polypeptide analogs evoke pancreatic beta-cell rest, enhance islet cell turnover, and inhibit food intake in mice.新型抗酶解胰多肽类似物可使小鼠胰腺β细胞休息、增强胰岛细胞更新并抑制食物摄入。
Biofactors. 2024 Nov-Dec;50(6):1101-1112. doi: 10.1002/biof.2059. Epub 2024 Apr 18.

本文引用的文献

1
Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes.重新审视胰多肽:在肥胖-糖尿病中的潜在治疗作用
Peptides. 2023 Feb;160:170923. doi: 10.1016/j.peptides.2022.170923. Epub 2022 Dec 9.
2
Effects and Mechanisms of Vagal Nerve Stimulation on Body Weight in Diet-Induced Obese Rats.迷走神经刺激对饮食诱导肥胖大鼠体重的影响及机制。
Obes Surg. 2020 Mar;30(3):948-956. doi: 10.1007/s11695-019-04365-7.
3
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors.2019/20 年药理学简明指南:G 蛋白偶联受体。
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S21-S141. doi: 10.1111/bph.14748.
4
Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.葡萄糖依赖性胰岛素促分泌多肽在人类中是一种胰多肽分泌素。
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgz097.
5
Peptide Therapeutics for Weight Loss: Preventing Plasma Pancreatic Polypeptide Proteolysis.用于减肥的肽疗法:防止血浆胰多肽蛋白水解。
Endocrinology. 2017 Jun 1;158(6):1567-1568. doi: 10.1210/en.2017-00393.
6
Influence of neuropeptide Y and pancreatic polypeptide on islet function and beta-cell survival.神经肽 Y 和胰多肽对胰岛功能和β细胞存活的影响。
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):749-758. doi: 10.1016/j.bbagen.2017.01.005. Epub 2017 Jan 7.
7
Role of the vagus nerve in the development and treatment of diet-induced obesity.迷走神经在饮食诱导性肥胖的发生发展及治疗中的作用
J Physiol. 2016 Oct 15;594(20):5791-5815. doi: 10.1113/JP271538. Epub 2016 May 29.
8
Alpha-, Delta- and PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination?α细胞、δ细胞和PP细胞:它们是胰岛结构与协调的架构基石吗?
J Histochem Cytochem. 2015 Aug;63(8):575-91. doi: 10.1369/0022155415583535.
9
Circulating pancreatic polypeptide concentrations predict visceral and liver fat content.循环中胰多肽的浓度可预测内脏脂肪和肝脏脂肪含量。
J Clin Endocrinol Metab. 2015 Mar;100(3):1048-52. doi: 10.1210/jc.2014-3450. Epub 2014 Dec 9.
10
Neuropeptide Y receptors: how to get subtype selectivity.神经肽 Y 受体:如何获得亚型选择性。
Front Endocrinol (Lausanne). 2013 Feb 4;4:5. doi: 10.3389/fendo.2013.00005. eCollection 2013.